Cochlear (COH) Share Forecast & Price Target

Compare

75 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

COH Analyst Ratings

Hold

3 Buy

6 Hold

1 Sell

Based on 10 analysts giving stock ratings to

Cochlear

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

COH Stock 12 Month Forecast

Average Price Target

AU$291.57

▼(-2.86%Downside)

Based on 10 Wall Street analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is AU$291.57 with a high forecast of AU$325.00 and a low forecast of AU$270.28. The average price target represents a -2.86% change from the last price of AU$300.17.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"255":"AU$255","340":"AU$340","276.25":"AU$276.3","297.5":"AU$297.5","318.75":"AU$318.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":324.99999927642324,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$325.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":291.5732327895,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$291.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":270.27999939825133,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$270.28</span>\n  </div></div>","useHTML":true}}],"tickPositions":[255,276.25,297.5,318.75,340],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,304.56,306.13230763664797,307.7046152732959,309.27692290994383,310.84923054659174,312.4215381832397,313.99384581988767,315.5661534565356,317.13846109318354,318.7107687298315,320.2830763664794,321.85538400312737,323.4276916397753,{"y":324.99999927642324,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,304.56,303.5610179068846,302.5620358137692,301.56305372065384,300.56407162753845,299.56508953442307,298.5661074413077,297.56712534819235,296.56814325507696,295.5691611619616,294.5701790688462,293.5711969757308,292.5722148826154,{"y":291.5732327895,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,304.56,301.92307687678857,299.28615375357714,296.6492306303657,294.0123075071543,291.37538438394284,288.7384612607314,286.1015381375199,283.4646150143085,280.82769189109706,278.19076876788563,275.5538456446742,272.91692252146277,{"y":270.27999939825133,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":331.024,"date":1711929600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 11</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":312.361,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":317.669,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":339.346,"date":1722470400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":289.094,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":282.775,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":287.567,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":317.079,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":256.794,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":265.01,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":273.6,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":304.56,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetAU$325.00

Average Price TargetAU$291.57

Lowest Price TargetAU$270.28

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

AU$330

Buy

9.94%

Upside

Reiterated

07/01/25

Cochlear Limited's score is primarily driven by its strong financial performance, showcasing robust revenue growth, profit margins, and a solid balance sheet. However, technical indicators suggest potential overvaluation with overbought conditions, influencing the score negatively. Valuation metrics indicate a high P/E ratio, further suggesting limited upside. The mixed outlook from the earnings call, marked by strong growth areas but offset by increased expenses and cloud investment, adds complexity to the investment thesis.

Craig Wong-PanRBC Capital

RBC Capital

AU$309→AU$294

Hold

-2.06%

Downside

Reiterated

07/16/25

Cochlear (CHEOF) Receives a Hold from RBC Capital

Unknown AnalystMacquarie

Not Ranked

Macquarie

AU$271.6→AU$270.5

Hold

-9.88%

Downside

Reiterated

07/16/25

Cochlear (CHEOF) Receives a Hold from Macquarie

Unknown AnalystOrd Minnett

Not Ranked

Ord Minnett

AU$285→AU$295

Hold

-1.72%

Downside

Reiterated

07/09/25

Cochlear (CHEOF) Receives a Hold from Ord Minnett

Sean LaamanMorgan Stanley

Morgan Stanley

AU$272

Sell

-9.38%

Downside

Reiterated

06/23/25

Morgan Stanley Sticks to Their Sell Rating for Cochlear (CHEOF)

Marcus CurleyUBS

UBS

AU$285→AU$325

Buy

8.27%

Upside

Upgraded

06/18/25

Positive Report for Cochlear (CHEOF) from UBS

Derek JellinekMorgans

Morgans

AU$281.36

Hold

-6.27%

Downside

Reiterated

06/17/25

Morgans Reaffirms Their Hold Rating on Cochlear (CHEOF)

Davinthra ThillainathanGoldman Sachs

Goldman Sachs

―

Hold

―

Reiterated

06/14/25

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM) and Cochlear (Other OTC: CHEOF)

David StantonJefferies

Jefferies

AU$311

Buy

3.61%

Upside

Reiterated

06/13/25

Jefferies Remains a Buy on Cochlear (CHEOF)

Steven WheenJarden

Jarden

AU$270.28

Hold

-9.96%

Downside

Reiterated

06/12/25

Cochlear (CHEOF) Receives a Hold from Jarden

David LowJ.P. Morgan

J.P. Morgan

AU$305

Buy

1.61%

Upside

Reiterated

06/12/25

J.P. Morgan Sticks to Its Buy Rating for Cochlear (CHEOF)

Andrew PaineCLSA

CLSA

AU$282.5→AU$290

Buy

-3.39%

Downside

Upgraded

03/17/25

CLSA Upgrades Cochlear Ltd. (COH:AU) (CHEOY) to Outperform (2)CLSA analyst Andrew Paine upgraded Cochlear Ltd. (COH:AU) (OTC: CHEOY) from Hold (3) to Outperform (2) with a price target of AUD290.00 (from AUD282.50).

Mathieu ChevrierCiti

Citi

AU$290→AU$300

Buy

-0.06%

Downside

Upgraded

03/05/25

Citi upgrades Cochlear Limited (CHEOF) to a Buy

Shane StoreyWilsons

Wilsons

AU$280

Hold

-6.72%

Downside

Downgraded

02/16/25

Wilsons downgrades Cochlear Limited (CHEOF) to a Hold

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

AU$330

Buy

9.94%

Upside

Reiterated

07/01/25

Craig Wong-PanRBC Capital

RBC Capital

AU$309→AU$294

Hold

-2.06%

Downside

Reiterated

07/16/25

Cochlear (CHEOF) Receives a Hold from RBC Capital

Unknown AnalystMacquarie

Not Ranked

Macquarie

AU$271.6→AU$270.5

Hold

-9.88%

Downside

Reiterated

07/16/25

Cochlear (CHEOF) Receives a Hold from Macquarie

Unknown AnalystOrd Minnett

Not Ranked

Ord Minnett

AU$285→AU$295

Hold

-1.72%

Downside

Reiterated

07/09/25

Cochlear (CHEOF) Receives a Hold from Ord Minnett

Sean LaamanMorgan Stanley

Morgan Stanley

AU$272

Sell

-9.38%

Downside

Reiterated

06/23/25

Morgan Stanley Sticks to Their Sell Rating for Cochlear (CHEOF)

Marcus CurleyUBS

UBS

AU$285→AU$325

Buy

8.27%

Upside

Upgraded

06/18/25

Positive Report for Cochlear (CHEOF) from UBS

Derek JellinekMorgans

Morgans

AU$281.36

Hold

-6.27%

Downside

Reiterated

06/17/25

Morgans Reaffirms Their Hold Rating on Cochlear (CHEOF)

Davinthra ThillainathanGoldman Sachs

Goldman Sachs

―

Hold

―

Reiterated

06/14/25

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (NASDAQ: TNDM) and Cochlear (Other OTC: CHEOF)

David StantonJefferies

Jefferies

AU$311

Buy

3.61%

Upside

Reiterated

06/13/25

Jefferies Remains a Buy on Cochlear (CHEOF)

Steven WheenJarden

Jarden

AU$270.28

Hold

-9.96%

Downside

Reiterated

06/12/25

Cochlear (CHEOF) Receives a Hold from Jarden

David LowJ.P. Morgan

J.P. Morgan

AU$305

Buy

1.61%

Upside

Reiterated

06/12/25

J.P. Morgan Sticks to Its Buy Rating for Cochlear (CHEOF)

Andrew PaineCLSA

CLSA

AU$282.5→AU$290

Buy

-3.39%

Downside

Upgraded

03/17/25

Mathieu ChevrierCiti

Citi

AU$290→AU$300

Buy

-0.06%

Downside

Upgraded

03/05/25

Citi upgrades Cochlear Limited (CHEOF) to a Buy

Shane StoreyWilsons

Wilsons

AU$280

Hold

-6.72%

Downside

Downgraded

02/16/25

Wilsons downgrades Cochlear Limited (CHEOF) to a Hold

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cochlear

1 Month

xxx

Success Rate

3/5 ratings generated profit

Average Return

0.00%

upgraded a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of 0.00% per trade.

3 Months

xxx

Success Rate

3/5 ratings generated profit

Average Return

+3.18%

upgraded a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +3.18% per trade.

1 Year

Mathieu ChevrierCiti

Success Rate

5/5 ratings generated profit

Average Return

+8.88%

upgraded a buy rating 5 months ago

Copying Mathieu Chevrier's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +8.88% per trade.

2 Years

xxx

Success Rate

5/5 ratings generated profit

Average Return

+8.88%

upgraded a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +8.88% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

COH Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, COH has received 6 Buy Ratings, 9 Hold Ratings, and 2 Sell Ratings. COH average Analyst price target in the past 3 months is 291.57.

Each month's total comprises the sum of three months' worth of ratings.

COH Financial Forecast

COH Earnings Forecast

Next quarter’s earnings estimate for COH is AU$2.94 with a range of AU$2.86 to AU$3.15. The previous quarter’s EPS was AU$3.14. COH beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.18% of the time in the same period. In the last calendar year COH has Preformed in-line its overall industry.

COH Sales Forecast

Next quarter’s sales forecast for COH is AU$1.19B with a range of AU$1.14B to AU$1.25B. The previous quarter’s sales results were AU$1.17B. COH beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year COH has Preformed in-line its overall industry.

COH Stock Forecast FAQ

What is AU:COH’s average 12-month price target, according to analysts?

Based on analyst ratings, Cochlear Limited’s 12-month average price target is 291.57.

What is AU:COH’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for AU:COH, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Cochlear Limited a Buy, Sell or Hold?

Cochlear Limited has a consensus rating of Hold, which is based on 3 buy ratings, 6 hold ratings and 1 sell ratings.

What is Cochlear Limited’s share price target?

The average share price target for Cochlear Limited is 291.57. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$325.00 ,and the lowest forecast is AU$270.28. The average share price target represents -2.86% Decrease from the current price of AU$300.17.

What do analysts say about Cochlear Limited?

Cochlear Limited’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Cochlear Limited?

To buy shares of AU:COH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Cochlear (COH) Share Forecast & Price Target

COH Analyst Ratings

COH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Cochlear

COH Analyst Recommendation Trends

COH Financial Forecast

COH Earnings Forecast

COH Sales Forecast

COH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts